Document is current
Any future updates will be listed below
-
Authors
Ding, Daisy Yi
Bot, Veronica Augustina https://orcid.org/0009-0008-5060-1142
Chen, Kenneth L.
Groves, James W. https://orcid.org/0000-0002-7803-8696
Pálovics, Róbert
Masuda, Daisuke https://orcid.org/0009-0001-1354-3245
Farinas, Amelia https://orcid.org/0000-0002-6697-8883
Oh, Hamilton Se-Hwee https://orcid.org/0000-0001-8192-7593
Wagner, Viktoria https://orcid.org/0000-0002-1957-0658
Lu, Nannan
,
Cruchaga, Carlos https://orcid.org/0000-0002-0276-2899
Isakova, Alina https://orcid.org/0000-0003-1113-6889
Schott, Jonathan M. https://orcid.org/0000-0003-2059-024X
Wyss-Coray, Tony https://orcid.org/0000-0001-5893-0831
- License Information
-
More Information
Article History
Received: 21 April 2025
Accepted: 4 May 2026
First Online: 15 June 2026
Competing interests
: T.W.-C. and H.S.-H.O. are co-founders and scientific advisors of Teal Omics Inc. and have received equity stakes. T.W.-C. is a co-founder and scientific advisor of Alkahest Inc. and Qinotto Inc. and has received equity stakes in these companies. C.C. has received research support from GSK and EISAI. C.C. is a member of the scientific advisory board of Circular Genomics and owns stocks and is also a member of the scientific advisory board of ADmit. J.M.S. has received research funding and PET tracer from AVID Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly) and Alliance Medical, and has consulted for Roche, Eli Lilly, Biogen, MSD, GE Healthcare, Alamar Biosciences and Receptive Bio, and is Chief Medical Officer for Alzheimer’s Research UK. The other authors declare no competing interests.
